Infensa Bioscience
PrivateLast Round
Grant
Oct 7, 2024
Total Funding Raised
$27.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Infensa Bioscience is a biotechnology company that develops peptide-based therapeutic candidates to reduce mortality and morbidity associated with heart attacks and strokes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infensa Bioscience Comparables
Compare Infensa Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurexis Therapeutics | 80% | |
| Forcefield Therapeutics | 79% | |
| NoNO Inc. | 78% |
Infensa Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 7, 2024 | ||||
| Series A | Jul 4, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 1811% from 47 to 898.
- Oct 7, 2024
$12.1M grant received from health-gov.
Infensa Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Infensa Bioscience's valuation, stock price, and market status.
Is Infensa Bioscience a public or private company?
Infensa Bioscience is a private company.
What is the current stock price of Infensa Bioscience?
Infensa Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Infensa Bioscience worth (valuation)?
Valuation information for Infensa Bioscience is not publicly available.
Can I buy Infensa Bioscience stock?
Infensa Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Infensa Bioscience's last funding round?
Infensa Bioscience's most recent funding round was Grant on October 7, 2024.
Who are the main investors in Infensa Bioscience?
Investor information for Infensa Bioscience is not publicly disclosed.
Will Infensa Bioscience IPO soon?
No public IPO plans have been announced for Infensa Bioscience.
How can I track Infensa Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Infensa Bioscience's secondary market activity and sign up for updates.